Although delivery systems are seemingly designed with beneficial intentions and streamlined utilization, a number of current practices and policies have been the subject of criticism and controversy. Two leaders in health policy shared their insights regarding these concerns and discussed the necessary steps to further improve an antiquated delivery system during changing times.
The second session of the 2012 America’s Health Insurance Plan’s Medicare and Medicaid Conferences on Monday featured a workshop titled “Delivery System Reform: A Look Back, a Look Forward,” led by 2 key speakers representing different policy institutes.
Robert A. Berenson, MD, FACP, a fellow at the Health Policy Center of the Urban Institute, began the presentation with what he described as “head scratchers.” These “head scratchers” covered a wide variety of current practices and policies that have seemingly beneficial intentions, but have actually resulted in, or currently cause, misappropriated resources, under- or overutilization, and mismanagement. The following is a brief list of the controversial practices that Dr Berenson contended should be reformed and remedied to improve the future of the healthcare delivery system:
Dr Berenson was followed by Mark B. McClellan, MD, PhD, the director and chair of health policy studies at the Engelberg Center for Health Care Reform in The Brookings Institute. He elaborated on the current trends of health delivery systems, noting a financial alignment to support increased value and the growth of practical experience, especially outside of integrated health systems. However, because much of the debate surrounding healthcare reform is rooted in further cost management without detracting from the quality of care, he noted that there must be supportive changes in financing and reallocating resources. In addition, there needs to be a capacity for measuring the impact of these reforms at the patient level, and increased leadership to promote communication about further beneficial opportunities, build trust, and implement new interactions across providers and settings that did not previously work together. Creating this novel environment of payer-provider collaboration with patient and consumer involvement, although necessary, will not be easy, Berenson admitted, but with enough momentum and the right support, it can be accomplished.
To learn more about this session, please visit the AHIP 2012 Medicare and Medicaid Conference website.
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Prostate Cancer Studies Show Why Personalized Treatment, Trial Diversity Matter, Dorff Says
February 21st 2025Tanya B. Dorff, MD, medical oncologist and professor in City of Hope’s Department of Medical Oncology & Therapeutics Research, was a discussant for the TALAPRO-2 and STOPCAP trials at the opening session of ASCO GU.
Read More
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More